標(biāo)題: Titlebook: Advances in Transplant Dermatology; Clinical and Practic Fiona Zwald,Marc D. Brown Book 2015 Springer International Publishing Switzerland [打印本頁] 作者: broach 時間: 2025-3-21 16:13
書目名稱Advances in Transplant Dermatology影響因子(影響力)
書目名稱Advances in Transplant Dermatology影響因子(影響力)學(xué)科排名
書目名稱Advances in Transplant Dermatology網(wǎng)絡(luò)公開度
書目名稱Advances in Transplant Dermatology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Advances in Transplant Dermatology被引頻次
書目名稱Advances in Transplant Dermatology被引頻次學(xué)科排名
書目名稱Advances in Transplant Dermatology年度引用
書目名稱Advances in Transplant Dermatology年度引用學(xué)科排名
書目名稱Advances in Transplant Dermatology讀者反饋
書目名稱Advances in Transplant Dermatology讀者反饋學(xué)科排名
作者: 粗俗人 時間: 2025-3-21 20:55
Advances in Photoprotection,d cancer in Ireland (Cancer in Ireland 2013: annual report of the national cancer registry; Chapter 4.1. .). Skin cancer is therefore a preventable disease for the most part. Strategies to reduce the exposure of UVR will reduce skin cancer risk. This is of particular relevance for pale skin types, w作者: Incorporate 時間: 2025-3-22 03:55
Update on Our Understanding of HPV as a Risk Factor for Cutaneous Squamous Cell Carcinoma in Organ most important risk factor for developing squamous cell carcinoma (SCC) in OTR. In the years after transplantation, OTR develop numerous warts and wart-like lesions followed by the development of SCC, which resembles the clinical picture of epidermodysplasia verruciformis patients in which human pap作者: 逢迎春日 時間: 2025-3-22 07:15 作者: 機(jī)制 時間: 2025-3-22 11:54
Advances in Photodynamic Therapy for the Treatment of Malignant and Premalignant Lesions in Transplbe more numerous, diffusely located, recurrent, and aggressive in OTRs compared to immunocompetent patients. Not surprisingly, cutaneous malignancy is therefore a leading cause of morbidity and mortality in the OTR population. Given this significant disease burden, a great deal of interest has focus作者: stressors 時間: 2025-3-22 13:33
,Update on Staging, Definition, and Chemoprevention of “High-Risk Squamous Cell Carcinoma” in Organ l carcinoma (SCC). In addition to increased risk of SCC development, OTRs experience a higher tumor burden, more aggressive SCCs, and increased risk of metastasis and skin cancer-related mortality, making staging, prognosis, and treatment determinations in OTR patients especially important, yet lack作者: 阻塞 時間: 2025-3-22 20:35 作者: GLOOM 時間: 2025-3-22 22:26 作者: anticipate 時間: 2025-3-23 04:13
Update in Melanoma in Organ Transplant Patients,eening transplant candidates to help identify a history of pretransplant melanoma or other high-risk factors for posttransplant melanoma. For those with a history of pretransplant melanoma, AJCC melanoma staging should help guide wait times prior to transplantation to ensure ethical allocation of a 作者: Comedienne 時間: 2025-3-23 09:18
aneous malignancies in solid organ transplant patients.WrittThis book provides an informative update on scientific advances relating to transplant dermatology that may be applicable to clinical practice. Commentary is provided on the emerging role of viruses in transplant dermatology, the management作者: Explicate 時間: 2025-3-23 12:09 作者: Mortal 時間: 2025-3-23 17:25
Advances in Our Understanding of Immunosuppression as a Risk Factor for Cutaneous SCC: Evidence forarcinoma (SCC) of the skin is a major complication of treatment with immunosuppressive drugs, with a 65- to 100-fold higher risk than in the normal population [2]. Other malignancies like basal cell carcinoma (BCC), melanoma, and internal malignancies increase as well but to a significantly lesser extent [3].作者: 向宇宙 時間: 2025-3-23 20:48
Book 2015tary is provided on the emerging role of viruses in transplant dermatology, the management of skin disease secondary to transplant medication, sunscreen use in transplant recipients, the role of revision of immunosuppression, and advances in photodynamic therapy. The latest staging and management cr作者: perjury 時間: 2025-3-24 01:35
Recognising and Resolving Conflicts,t of benign and inflammatory disorders in SOTR will be reviewed, with particular emphasis on the transplant immunosuppressive regimens as well as general and specific and their general as well as drug dermatologic consequences.作者: LATE 時間: 2025-3-24 03:39 作者: 防止 時間: 2025-3-24 07:13
Negotiations Leading to Conflict Resolution, cell carcinoma—with a tendency towards increased risk of recurrence, metastasis, and an association with a poorer prognosis—is also seen in this population. As such, careful consideration must be made with respect to the management of “high-risk” lesions in these patients.作者: Affable 時間: 2025-3-24 14:39
Update on Benign and Inflammatory Skin Disease Secondary to Transplant Medication,t of benign and inflammatory disorders in SOTR will be reviewed, with particular emphasis on the transplant immunosuppressive regimens as well as general and specific and their general as well as drug dermatologic consequences.作者: MIR 時間: 2025-3-24 16:22 作者: 輕而薄 時間: 2025-3-24 22:19 作者: 套索 時間: 2025-3-25 03:10
James E. Crowfoot,Mark A. Cheslerions simultaneously with excellent cosmetic outcomes, photodynamic therapy (PDT) is an attractive therapeutic option. Here we review the clinical data for the treatment and prevention of NMSC in OTR using PDT, including pretreatment and treatment considerations and associated risks.作者: 憲法沒有 時間: 2025-3-25 05:09
Conflict Prevention in Project Managementg of decreased immunity. Organ transplant recipients tend to develop MCCs at an earlier age and show decreased MCC-specific and overall survival when compared to the general population. Mechanism-based therapies and viral antigen–directed therapies are in the early stages of development but show promise as targeted therapies.作者: 敏捷 時間: 2025-3-25 10:51
https://doi.org/10.1007/978-3-540-77437-2iated with a worse prognosis. While donor-derived melanoma is rare in transplant patients, it has been reported as the most commonly transmitted tumor-causing distant metastasis and is associated with a poor overall survival.作者: 愛社交 時間: 2025-3-25 13:35 作者: Geyser 時間: 2025-3-25 16:19
Advances in Management of Merkel Cell Carcinoma in Organ Transplant Recipients: Role of Polyoma Virg of decreased immunity. Organ transplant recipients tend to develop MCCs at an earlier age and show decreased MCC-specific and overall survival when compared to the general population. Mechanism-based therapies and viral antigen–directed therapies are in the early stages of development but show promise as targeted therapies.作者: glacial 時間: 2025-3-25 21:01 作者: Enrage 時間: 2025-3-26 02:51
Book 2015ideration in solid organ transplant patients. Each particular advance is addressed in an individual chapter by leaders in the field. The book both expands current knowledge and complements previous textbooks on the subject.作者: 付出 時間: 2025-3-26 05:23
umors that also behave aggressively and require special consideration in solid organ transplant patients. Each particular advance is addressed in an individual chapter by leaders in the field. The book both expands current knowledge and complements previous textbooks on the subject.978-3-319-34805-6978-3-319-12445-2作者: Graduated 時間: 2025-3-26 10:18 作者: 蛤肉 時間: 2025-3-26 12:46
Gerard B. J. Bomers,Richard B. Petersonimmunosuppressed OTR population. With no universally accepted standard definition of high-risk features, the different high-risk factors proposed by several consensus guidelines require individual exploration. OTRs also represent a desirable target for chemoprevention of SCCs, and while only oral re作者: 誘使 時間: 2025-3-26 17:32 作者: 狗窩 時間: 2025-3-26 23:39
,Update on Staging, Definition, and Chemoprevention of “High-Risk Squamous Cell Carcinoma” in Organ immunosuppressed OTR population. With no universally accepted standard definition of high-risk features, the different high-risk factors proposed by several consensus guidelines require individual exploration. OTRs also represent a desirable target for chemoprevention of SCCs, and while only oral re作者: ticlopidine 時間: 2025-3-27 03:09
Recognising and Resolving Conflicts,pressant medications. Immunodeficiency leads to increased risk of a variety of infections, inflammatory disorders, and benign skin neoplasms. Aside from indirect side effects, many medications medications have direct effects on the skin structures as well. The presentation, evaluation, and managemen作者: 去世 時間: 2025-3-27 08:12
André F. M. Wierdsma,Gerard B. J. Bomersd cancer in Ireland (Cancer in Ireland 2013: annual report of the national cancer registry; Chapter 4.1. .). Skin cancer is therefore a preventable disease for the most part. Strategies to reduce the exposure of UVR will reduce skin cancer risk. This is of particular relevance for pale skin types, w作者: 伸展 時間: 2025-3-27 10:00
Conflict Control and Industrial Reform: ,most important risk factor for developing squamous cell carcinoma (SCC) in OTR. In the years after transplantation, OTR develop numerous warts and wart-like lesions followed by the development of SCC, which resembles the clinical picture of epidermodysplasia verruciformis patients in which human pap作者: nettle 時間: 2025-3-27 17:37
Decision-Making Processes and Conflicter, Merkel cell carcinoma, and Kaposi’s sarcoma, as well as other transplant-associated cancers compared to the normal population [1]. Squamous cell carcinoma (SCC) of the skin is a major complication of treatment with immunosuppressive drugs, with a 65- to 100-fold higher risk than in the normal po作者: 意外的成功 時間: 2025-3-27 21:07
James E. Crowfoot,Mark A. Cheslerbe more numerous, diffusely located, recurrent, and aggressive in OTRs compared to immunocompetent patients. Not surprisingly, cutaneous malignancy is therefore a leading cause of morbidity and mortality in the OTR population. Given this significant disease burden, a great deal of interest has focus作者: agitate 時間: 2025-3-28 01:22 作者: placebo 時間: 2025-3-28 03:58 作者: 生命 時間: 2025-3-28 08:51 作者: Distribution 時間: 2025-3-28 14:29 作者: deface 時間: 2025-3-28 15:18
https://doi.org/10.1007/978-3-319-12445-2Organ transplantation recipients; Photoprotection; Risk factors; Skin tumors; Viral infection作者: 蛛絲 時間: 2025-3-28 20:28 作者: Popcorn 時間: 2025-3-29 01:51 作者: 詢問 時間: 2025-3-29 03:45
